A panel of clinicians and managed care decision makers describe how to best refer to real-world evidence when making treatment decisions for patients with multiple myeloma.
EP. 1: Coming Soon: Real-World Evidence in the Evolving Treatment Landscape of Multiple Myeloma
EP. 2: A Multiple Myeloma Overview
Muhamed Baljević, MD, FACP, provides a background of multiple myeloma (MM) within the past five years and the main treatment options.
EP. 3: MM and Regimens for First- and Second-Line Treatment
Joshua Richter, MD, and Roy Beveridge, MD, explain the role triplet regimens play in MM treatment and how physician decision-making has been impacted since the NCCN guidelines have expanded the list of acceptable first- and second-line treatment options.
EP. 4: MM From the Payers’ Perspective
Dr Beveridge provides a payer’s perspective on the available regimens for MM treatment.
EP. 5: MM Healthcare Resource Utilization
The panel discusses the data used to evaluate healthcare resources for MM therapy, as well as economic burden.
EP. 6: Decision Support Tools for MM
A panel of experts elaborate on the decision support tools that are utilized by physicians to give patients high-value regimens.
EP. 7: MM and the Limitations of RCT Data
Dr Baljević explain some of the limitations physicians can come across with applying randomized clinical trial (RCT) data to MM treatment.
EP. 8: MM and Real-World Evidence
Dr Richter relays some of the differences between real-world evidence (RWE) and RCT data, as well as how they can work together when determining therapy.
EP. 9: The Value of RWE in MM
Jay Weaver, PharmD, MPH, and Muhamed Baljević, MD, FACP, discuss how RWE can affect the management of MM.
EP. 10: Incorporating RWE in MM Decision-Making
The panel elaborate on how they’ve incorporated RWE into their decision-making processes for their patients with MM.
EP. 11: RWE Decision-Making Barriers
Dr Beveridge explains potential barriers a physician can encounter when implementing RWE into MM therapy.
EP. 12: MM and Non-Comparative RWE
The panel moves the discussion to non-comparative RWE and how that can play a part in their decision-making for MM therapy.
EP. 13: Educating on RWE
Dr Richter delves into how we can better educate patients and physicians on RWE to improve decision-making.
EP. 14: MM Unmet Needs
Dr Baljević discusses unmet needs that are typically seen in the management of MM.
EP. 15: Incorporating RWE Into Future Decision-Making
Our panel concludes with their plans to incorporate RWE into MM management in the future.
2 Commerce Drive Cranbury, NJ 08512